搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Frontiers
1 天
Exploring the Intersection of Cancer Metabolism, Metastasis and Immunotherapy
Cancer metabolism is a critical area of research, central to understanding how malignant tumors manipulate metabolic pathways to support their growth and survival. These alterations not only fuel ...
Opinion
18 小时
Opinion
Her medical file read 'death imminent.' His treatment plan changed cancer forever. | Opinion
Immunotherapy is the brightest new weapon in fight against cancer. Thank Dr. Steven Rosenberg, who 40 years ago successfully ...
News Medical
14 小时
Targeted therapy induces regression in colorectal liver metastases
Explore how E-selectin-targeted polymer-doxorubicin therapy induces regression in colorectal liver metastases.
4 天
多张WB条带重复,上海市第一人民医院的论文被撤稿
本文已被撤回:在图5D中,同一张Western blot图像被用于HT29和HCT116细胞组。作者无法使用原始数据进行修正。因此,编辑决定撤回此论文。所有作者都同意这一决定。上海交通大学有关部门已获悉该论文存在的问题。
Cure Today
2 天
Overcoming Hormone Therapy Resistance in Metastatic Breast Cancer
An expert discusses the next steps for patients with metastatic breast cancer after their disease no longer responds to ...
The American Journal of Managed Care
15 小时
Elacestrant Shows Significant PFS Benefit in ESR1-Mutated Metastatic Breast Cancer
Elacestrant, a selective estrogen receptor degrader, demonstrated significant improvements in progression-free survival (PFS) ...
Cure Today
11 天
COVID-19 RNA May Be Linked to Metastatic Cancer Regression
RNA from the COVID-19 infection in patients with certain metastatic cancers may be associated with tumor shrinkage, but more ...
Business Wire
2 天
European Commission Approves BeiGene’s TEVIMBRA for First-Line Treatment of Advanced ...
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne ...
Medpage Today on MSN
4 天
Early Promise for PI3K Inhibitor in Brain Metastases
HOUSTON -- Two-thirds of patients with PI3K -mutant brain metastases responded to the maximum tolerated dose (MTD) of the ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈